TGM2
Protein-glutamine gamma-glutamyltransferase 2
Also known as: TGC, TGM2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P21980
- Gene
- TGM2
- Ensembl
- ENSG00000198959
- Chromosome
- 20
- Canonical length
- 687 aa
- Protein class
- Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins
- Subcellular location
- Plasma membrane,Cytosol
- Secretome location
- Secreted to extracellular matrix
- Quaternary structure
- Homooligomer
OverviewNCBI Gene
Transglutaminases are enzymes that catalyze the crosslinking of proteins by epsilon-gamma glutamyl lysine isopeptide bonds. While the primary structure of transglutaminases is not conserved, they all have the same amino acid sequence at their active sites and their activity is calcium-dependent. The protein encoded by this gene acts as a monomer, is induced by retinoic acid, and appears to be involved in apoptosis. Finally, the encoded protein is the autoantigen implicated in celiac disease. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
687 residues, UniProt reviewed canonical sequence.
>P21980|TGM2
1 MAEELVLERC DLELETNGRD HHTADLCREK LVVRRGQPFW LTLHFEGRNY EASVDSLTFS
61 VVTGPAPSQE AGTKARFPLR DAVEEGDWTA TVVDQQDCTL SLQLTTPANA PIGLYRLSLE
121 ASTGYQGSSF VLGHFILLFN AWCPADAVYL DSEEERQEYV LTQQGFIYQG SAKFIKNIPW
181 NFGQFEDGIL DICLILLDVN PKFLKNAGRD CSRRSSPVYV GRVVSGMVNC NDDQGVLLGR
241 WDNNYGDGVS PMSWIGSVDI LRRWKNHGCQ RVKYGQCWVF AAVACTVLRC LGIPTRVVTN
301 YNSAHDQNSN LLIEYFRNEF GEIQGDKSEM IWNFHCWVES WMTRPDLQPG YEGWQALDPT
361 PQEKSEGTYC CGPVPVRAIK EGDLSTKYDA PFVFAEVNAD VVDWIQQDDG SVHKSINRSL
421 IVGLKISTKS VGRDEREDIT HTYKYPEGSS EEREAFTRAN HLNKLAEKEE TGMAMRIRVG
481 QSMNMGSDFD VFAHITNNTA EEYVCRLLLC ARTVSYNGIL GPECGTKYLL NLNLEPFSEK
541 SVPLCILYEK YRDCLTESNL IKVRALLVEP VINSYLLAER DLYLENPEIK IRILGEPKQK
601 RKLVAEVSLQ NPLPVALEGC TFTVEGAGLT EEQKTVEIPD PVEAGEEVKV RMDLLPLHMG
661 LHKLVVNFES DKLKAVKGFR NVIIGPALocalizationUniProt · AlphaFold · HPA
Whether an antibody against TGM2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.22
- Highest tissue expression
- 776 nTPM
Expression across tissuesHPA
Tissue
- blood vessel: 776 nTPM
- cervix: 413 nTPM
- heart muscle: 391 nTPM
- lung: 295 nTPM
- endometrium: 264 nTPM
- liver: 246 nTPM
Single-cell type
- decidual stromal cells: 1,215 nCPM
- epididymal efferent duct absorptive cells: 825 nCPM
- syncytiotrophoblasts: 454 nCPM
- cytotrophoblasts: 400 nCPM
- endometrial stromal cells: 343 nCPM
- lymphatic endothelial cells: 299 nCPM
Immune cell
- intermediate monocyte: 0.6 nTPM
- myeloid DC: 0.6 nTPM
- memory B-cell: 0.4 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- choroid plexus: 78 nTPM
- thalamus: 34 nTPM
- pons: 25 nTPM
- medulla oblongata: 24 nTPM
- spinal cord: 21 nTPM
- white matter: 21 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about TGM2.
Disease | ImmuneIEDB
Conditions an epitope on TGM2 was assayed in.
- celiac disease B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against TGM2 are reported. Each links to that disease's full target list.
- Celiac Disease 816
- Diabetes Mellitus, Type 1 98
- Thyroiditis, Autoimmune 13
- Crohn Disease 10
- Inflammatory Bowel Diseases 10
- Arthritis, Rheumatoid 8
- Glomerulonephritis, IGA 8
- Arthritis, Juvenile 6
- COVID-19 6
- Sjogren's Syndrome 6
- Graves Disease 5
- Liver Cirrhosis 5
- Liver Cirrhosis, Biliary 5
- Lupus Erythematosus, Systemic 5
- Schizophrenia 5
- Addison Disease 4
- Anemia 4
- Ataxia 4
- Colitis, Ulcerative 4
- Hashimoto Disease 4
Showing 20 of 43 — disease pages carrying at least 10 antigens.
ReferencesPubMed · IEDB
Publications for TGM2 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
952 publications
- European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.
2012 · J Pediatr Gastroenterol Nutr · RCR 71.5 · 1,922 citations - European Society Paediatric Gastroenterology, Hepatology and Nutrition Guidelines for Diagnosing Coeliac Disease 2020.
2020 · J Pediatr Gastroenterol Nutr · RCR 62.9 · 858 citations - Global Prevalence of Celiac Disease: Systematic Review and Meta-analysis.
2018 · Clin Gastroenterol Hepatol · RCR 59.7 · 1,069 citations - Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.
2003 · Arch Intern Med · RCR 37.1 · 1,219 citations - Guideline for the diagnosis and treatment of celiac disease in children: recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.
2005 · J Pediatr Gastroenterol Nutr · RCR 25.4 · 759 citations
Show 20 more of 952 total
- Prevalence of Celiac disease among children in Finland.
2003 · N Engl J Med · RCR 20.4 · 703 citations - The prevalence of celiac disease in the United States.
2012 · Am J Gastroenterol · RCR 19.4 · 533 citations - The Immunobiology and Pathogenesis of Celiac Disease.
2023 · Annu Rev Pathol · RCR 17.9 · 146 citations - Autoantibodies to tissue transglutaminase as predictors of celiac disease.
1998 · Gastroenterology · RCR 14.7 · 494 citations - Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease.
1998 · Gastroenterology · RCR 13 · 487 citations - Celiac disease: from pathogenesis to novel therapies.
2009 · Gastroenterology · RCR 12.2 · 421 citations - Divergence of gut permeability and mucosal immune gene expression in two gluten-associated conditions: celiac disease and gluten sensitivity.
2011 · BMC Med · RCR 11 · 330 citations - Current concepts of celiac disease pathogenesis.
2000 · Gastroenterology · RCR 10.7 · 380 citations - Advances in diagnosis and management of celiac disease.
2015 · Gastroenterology · RCR 9.2 · 184 citations - Looking back at the TEDDY study: lessons and future directions.
2025 · Nat Rev Endocrinol · RCR 8.8 · 26 citations - Update on serologic testing in celiac disease.
2010 · Am J Gastroenterol · RCR 8.7 · 251 citations - Serum anti-tissue transglutaminase IgA and prediction of duodenal villous atrophy in adults with suspected coeliac disease without IgA deficiency (Bi.A.CeD): a multicentre, prospective cohort study.
2023 · Lancet Gastroenterol Hepatol · RCR 8.3 · 50 citations - Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.
2017 · Gastroenterology · RCR 8 · 166 citations - Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.
2016 · Am J Gastroenterol · RCR 7.7 · 157 citations - Incidence of Pediatric Celiac Disease Varies by Region.
2023 · Am J Gastroenterol · RCR 7.4 · 38 citations - Kinetics of the histological, serological and symptomatic responses to gluten challenge in adults with coeliac disease.
2013 · Gut · RCR 7.2 · 183 citations - Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.
2013 · Schizophr Res · RCR 6.3 · 180 citations - Association of Gluten Intake During the First 5 Years of Life With Incidence of Celiac Disease Autoimmunity and Celiac Disease Among Children at Increased Risk.
2019 · JAMA · RCR 6.2 · 109 citations - Screening for Celiac Disease in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-analysis.
2017 · Am J Gastroenterol · RCR 6 · 115 citations - Serum I-FABP as marker for enterocyte damage in coeliac disease and its relation to villous atrophy and circulating autoantibodies.
2013 · Aliment Pharmacol Ther · RCR 6 · 168 citations
Reference: B cellIEDB
2 publications
- Synthetic peptides reproducing tissue transglutaminase-gliadin complex neo-epitopes as probes for antibody detection in celiac disease patients' sera.
2015 · J Med Chem · RCR 0.3 · 8 citations - Epitope mapping of the N-terminal portion of tissue transglutaminase protein antigen to identify linear epitopes in celiac disease.
2014 · J Pept Sci · RCR 0.2 · 4 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.19
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.54
- DepMap mean gene effect
- 0.11
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- apoptotic cell clearance
- bone development
- branching involved in salivary gland morphogenesis
- cellular response to cocaine
- cellular response to dopamine
- cellular response to serotonin
- negative regulation of endoplasmic reticulum calcium ion concentration
- peptide cross-linking
- phospholipase C-activating G protein-coupled receptor signaling pathway
- positive regulation of apoptotic process
- positive regulation of cell adhesion
- positive regulation of GTPase activity
- positive regulation of mitochondrial calcium ion concentration
- positive regulation of neurogenesis
- positive regulation of small GTPase mediated signal transduction
- positive regulation of sprouting angiogenesis
- protein deamination
- protein homooligomerization
- proteolysis
- regulation of apoptotic process
- salivary gland cavitation
- regulation of apoptotic cell clearance
Molecular functions
- calcium ion binding
- GTP binding
- peptidase activity
- protein-glutamine gamma-glutamyltransferase activity
- histone dopaminyltransferase activity
- histone serotonyltransferase activity
- peptide histaminyltransferase activity
- peptide noradrenalinyltransferase activity
- protein-glutamine glutaminase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Transglutaminase, N-terminal
- Transglutaminase-like
- Transglutaminase, C-terminal
- Immunoglobulin-like fold
- Transglutaminase, active site
- Immunoglobulin E-set
- Protein-glutamine gamma-glutamyltransferase, animal
- Transglutaminase, C-terminal domain superfamily
- Transglutaminase-like superfamily
- Papain-like cysteine peptidase superfamily
- Protein-glutamine gamma-glutamyltransferases
- Transglutaminase family
- Transglutaminase family, C-terminal ig like domain
- Transglutaminase-like superfamily
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of TGM2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads TGM2 as an antibody target. Whether an autoantibody or antibody against TGM2 could matter depends on whether native TGM2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
TGM2 is annotated at the cell surface, where native TGM2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Source-annotated serology context
The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.
- Finally, the encoded protein is the autoantigen implicated in celiac disease.
Loading the interactive Seroatlas protein explorer...